Laser company for medical applications – Modulight

Semiconductor development
Original semiconductor laser design & manufacturing

We believe that the laser diodes should be optimized for your application - not vice versa!

Photodynamic therapy
Lasers for many oncological indications

Modulight's proven platform ML7710 is the most versatile and proven platform in the industry, used for many different cancer therapies. We are helping our customers in all phases from pre-clinical and clinical trials to approved PMAs.

Semiconductor
Semiconductor laser expertise

Our 500+ years of engineering experience in designing & manufacturing diode lasers has made us a long-term strategic partner for many companies for the laser chip needs.

Ophthalmology
Ophthalmic lasers

Lasers are used in ophthalmology for many indications, such as treating ocular tumors, glaucoma, and intraretinal vascular abnormalities.

In-vitro
In-vitro research

Controlled and repeatable lighting is essential for in-vitro and in-vivo studies of photoreactive components. Modulight’s in-vitro and in-vivo product family supports all existing photosensitizers.

previous arrow
next arrow

We are the laser expert in your team

We’re helping people with their novel ideas. We have experience in productization, manufacturing subassemblies in regular production, as well as working to support end-of-life as equally important phase in the life cycle of a medical product.

Modulight products in spotlight

ML7710

ML7710 is truly the most versatile multichannel & multi-indication laser in the world. The treatment flow has been optimized and it can be further customized to specific needs. ML7710 supports all know photosensitizers. As the only true medical laser platform it also boasts unmatched security for the investment.

ML8500

ML8500 is an automatic system for illuminating well plates. ML8500 has up to six built-in lasers. Cloud-based composing of illumination programs can be done remotely which enables effective research work. ML8500 keeps sample plates within specified temperature and CO2 range.

ML6600

ML6600 is a small plug-and-play laser system with up to 3 lasers of different wavelengths built-in. ML6600 is designed for users that don’t have time or interest for all the complexity with drivers, cooling, power supplies, etc. Just unbox it, and take into use! When ordering, you may request 1–3 wavelengths from the wavelength range 400–2000 nm.

View the list of all Modulight products here. The list can be filtered by wavelength, power, and other parameters as needed.

Modulight in social media

Meet Modulight team

Latest news and articles

Modulight Spotlights: LASER-SHARP RESEARCH – April 2021

Modulight Spotlights: LASER-SHARP RESEARCH – April 2021 Dr. Rhonda Kines and the team at Aura Biosciences reported promising results of their VLP (virus-like particle) photosensitizer-conjugate eliciting strong and long-lasting anti-tumor immune responses, as well as potential to combine this agent with immune checkpoint inhibitors for even improved antitumor efficacy. Read original publication   Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!   #LaserSharpResearch #ModulightInScience   #LasersInScience #KillCancer #UvealMelanoma   Modulight products used: Continue reading →

Monitoring tissue responses to vascular-targeted PDT (VTP) in high resolution

Basic Info of the Study Research by: Memorial Sloan Kettering Cancer Center is one of the world’s premier cancer centers, collaborating with Weizmann Institute of Science research group. Modulight products: ML7710 (753 nm) Laser use: Study effects of vascular-targeted PDT (VTP) in mouse xenograft models Link to the study: Dr. Kwanghee Kim Dr. Avigdor Scherz   Vascular-targeted photodynamic therapy Vascular-targeted photodynamic therapy (VTP) is the latest form of PDT. It was initially developed by Avigdor Scherz (Weizmann Institute of Science), and it’s now owned by Steba Continue reading →

In vitro illumination using ML8500: osmium-based anticancer photosensitizer with highest hypoxic activity reported to date

Basic Info of the Study Research by: University of Texas at Arlington, US. One of the leading groups in photoactive drug discovery. Developed first clinical-level rubidium-based PS (TLD-1433), now in Theralase-sponsored Phase 2 trials for bladder cancer. Modulight products: ML8500 (445 nm, 525 nm, 630 nm, 753 nm, 810 nm) Laser use: Photoactive drug discovery Dr. Sherri McFarland (see her referral of Modulight) Research topics: Medicinal inorganic chemistry and drug discovery. Special interest in synthesis of novel transition metal complexes and studying their interactions with light Continue reading →

Subscribe to Modulight newsletter

We are sending out a newsletter to our friends and customers a few times per year. Stay informed about what is going on and subscribe! You can always as easily opt-out.

    Name *


    Email *